KY19382, a novel activator of Wnt/β-catenin signalling, promotes hair regrowth and hair follicle neogenesis.

Yeong Chan RyuDong-Hwan LeeJiyong ShimJiyeon ParkYou-Rin KimSehee ChoiSoon Sun BakYoung Kwan SungSoung-Hoon LeeKang-Yell Choi

Published in: British journal of pharmacology (2021)

These results indicate that KY19382 is a potential therapeutic drug that exhibits effective hair regeneration ability via activation of the Wnt/β-catenin signalling for alopecia treatments.

Keyphrases

cell proliferation
stem cells
epithelial mesenchymal transition
emergency department
signaling pathway
drug induced
adverse drug